Webdisclosure.com

Search

GIMV (EBR:GIMB) Gimv invests in SynOx Therapeutics which raises EUR 37 million to develop emactuzumab for treatment of tenosynovial giant cell tumors

Directive transparence : information réglementée

19/11/2020 07:30